The particulars: date of analysis · TFC.
I would like to define my thresholds before I have a result, for obvious reasons.
I want a plan with explicit stopping rules, not just steps.
What is the minimum version of this that is still defensible?
What a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.
The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
| Component | Typical share | Counted in purity? | Counted in content? |
|---|---|---|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
On the detail: batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsOn the detail: the certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
Concretely, writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
If the certificate does not trace to your vial, it is not evidence about your vial.
A useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.
My working rule is that a document without a lot number, a method section and a test date is marketing.
To be exact about it, what makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.
Ask whether the certificate answers the question you are actually asking, because the answer is often no.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.